ReviewInternational journal of immunopathology and pharmacology
Development of RNase P ribozyme-based therapy against oral herpesvirus infections by HSV-1 and KSHV.
Thomas Sorrell et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.